Related Experiment Video

Updated: Nov 8, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.1K

The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond

Sonika Sethi1, Aditi Kumar2, Anandadeep Mandal3

  • 1The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK. sonika.sethi1@nhs.net.

Trials
|April 21, 2021
PubMed

Insights

Recruiting diverse participants for COVID-19 vaccine trials is crucial for generalizability. Targeted public health campaigns are needed to boost participation among the elderly, ethnic minorities, and rural populations.

Area of Science:

  • Clinical Trials
  • Vaccinology
  • Public Health

Background:

  • COVID-19 vaccine development necessitates representative participant populations for accurate safety and efficacy conclusions.
  • Current clinical trials often lack diversity in age, ethnicity, and comorbidities, challenging trial management and generalizability.
  • Failure to achieve representative recruitment can reduce the validity of study results and cause costly delays in drug development.

Purpose of the Study:

  • To investigate factors influencing public perception and participation in COVID-19 vaccination trials.
  • To identify demographic and geographic characteristics associated with vaccine trial interest.

Main Methods:

  • An anonymous, cross-sectional online survey was distributed across the United Kingdom.
  • Statistical analysis involved six phases, including multinomial logistic models.
  • The study examined demographic and geographic factors impacting vaccine trial participation.

Main Results:

  • Out of 4884 participants, 41.4% expressed interest in joining vaccine trials, while 27.6% were not interested and 31.1% were unsure.
  • Higher interest was observed in males, graduates, middle-aged adults (40-59), and individuals with no health issues.
  • Lower interest was noted among Black Asian and Minority Ethnic (BAME) individuals, those from rural areas, and older adults (70+).

Conclusions:

  • Engaging diverse participant cohorts is essential for developing generalizable COVID-19 vaccines.
  • Public health campaigns should focus on improving trial recruitment rates for underrepresented groups, including the elderly, BAME communities, and less educated rural populations.
Abstract

Keywords:
BAMECOVID-19Population surveyVaccination trialsVaccine

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.9K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.8K

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
51
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
223
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
58
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.1K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
522